AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

Nina Ditsch a Michael Untch b Marc Thill c Volkmar Müller d Wolfgang Janni e Ute-Susann Albert f Ingo Bauerfeind g Jens Blohmer h Wilfried Budach i Peter Dall j Ingo Diel k Peter A. Fasching l Tanja Fehm m Michael Friedrich n Bernd Gerber o Volker Hanf p Nadia Harbeck a Jens Huober e Christian Jackisch q Cornelia Kolberg-Liedtke h Hans-Heinrich Kreipe r David Krug s Thorsten Kühn t Sherko Kümmel u Sibylle Loibl v Diana Lüftner w Michael Patrick Lux x Nicolai Maass y Volker Möbus z Markus Müller-Schimpfle A Christoph Mundhenke y Ulrike Nitz B Kerstin Rhiem C Achim Rody D Marcus Schmidt E Andreas Schneeweiss F Florian Schütz G Hans-Peter Sinn H Christine Solbach I Erich-Franz Solomayer J Elmar Stickeler K Christoph Thomssen L Frederik Wenz M Isabell Witzel d Achim Wöckel N

• Publication year

  2019

• Venue

  Breast Care

• Publication date

  2019-08-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1159/000501000PMID 31558897PMCID PMC6751475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Imaging Reporting and Data System

  2020cited by this paper
• Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

  2019cited by this paper
• High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

  2019cited by this paper
• PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

  2019cited by this paper
• Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

  2019cited by this paper
• West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.

  2019cited by this paper
• Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.

  2019cited by this paper
• US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients

  2019cited by this paper
• Trastuzumab Emtansine for Residual Invasive HER2‐Positive Breast Cancer

  2019cited by this paper
• Abstract P2-08-01: Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy – Results of a pooled analysis based on the GBG meta-database

  2019cited by this paper
• Risk Reduction and Survival Benefit of Risk‐Reducing Salpingo‐oophorectomy in Hereditary Breast Cancer: Meta‐analysis and Systematic Review

  2019cited by this paper
• Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

  2019cited by this paper
• Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies

  2019cited by this paper
• Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group.

  2018cited by this paper
• Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial

  2018cited by this paper
• Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

  2018cited by this paper
• Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy

  2018cited by this paper
• Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction

  2018cited by this paper
• Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer

  2018cited by this paper
• BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.

  2018cited by this paper
• Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

  2018cited by this paper
• Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study

  2018cited by this paper
• Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

  2018cited by this paper
• Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

  2018cited by this paper
• Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

  2018cited by this paper
• The prognostic value of circulating cell-free DNA in breast cancer

  2018cited by this paper
• Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

  2018cited by this paper
• Breast Implant-Associated Lymphoma.

  2018cited by this paper
• Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

  2018cited by this paper
• Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto

  2018cited by this paper
• Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

  2018cited by this paper
• Association between whole grain intake and breast cancer risk: a systematic review and meta-analysis of observational studies

  2018cited by this paper
• Effects of physical exercise on breast cancer-related secondary lymphedema: a systematic review

  2018cited by this paper
• A contemporary review of male breast cancer: current evidence and unanswered questions

  2018cited by this paper
• Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

  2018cited by this paper
• The Benefits of Dietary Fiber Intake on Reducing the Risk of Cancer: An Umbrella Review of Meta‐analyses

  2018cited by this paper
• Margins in Breast-Conserving Surgery After Neoadjuvant Therapy

  2018cited by this paper
• Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

  2018cited by this paper
• Can yoga have any effect on shoulder and arm pain and quality of life in patients with breast cancer? A randomized, controlled, single-blind trial.

  2018cited by this paper
• Predictive value of circulating cell-free DNA in the survival of breast cancer patients

  2018cited by this paper
• Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

  2018cited by this paper
• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

  2018cited by this paper
• Inflammatory Breast Cancer: Updates on diagnosis and treatment options.

  2018cited by this paper
• Mind‐body interventions for fear of cancer recurrence: A systematic review and meta‐analysis

  2018cited by this paper
• The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

  2018cited by this paper
• Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database

  2018cited by this paper
• Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.

  2018cited by this paper
• Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer.

  2018cited by this paper
• Atezolizumab and Nab‐Paclitaxel in Advanced Triple‐Negative Breast Cancer

  2018cited by this paper
• Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.

  2018cited by this paper
• Papillary lesions of the breast: To excise or observe?

  2018cited by this paper
• Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions.

  2017cited by this paper
• Effect of acupuncture on hot flush and menopause symptoms in breast cancer- A systematic review and meta-analysis

  2017cited by this paper
• Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

  2017cited by this paper
• Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors

  2017cited by this paper
• Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

  2017cited by this paper
• Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials

  2017cited by this paper
• Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

  2017cited by this paper
• The effect of population‐based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow‐up

  2017cited by this paper
• GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

  2017cited by this paper
• Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.

  2017cited by this paper
• The Mechanisms and Effects of Physical Activity on Breast Cancer

  2017cited by this paper
• Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

  2017cited by this paper
• Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta‐analysis

  2017cited by this paper
• Adjuvant Pertuzumab and Trastuzumab in Early HER2‐Positive Breast Cancer

  2017cited by this paper
• Five-Year Safety Data for More than 55,000 Subjects following Breast Implantation: Comparison of Rare Adverse Event Rates with Silicone Implants versus National Norms and Saline Implants

  2017cited by this paper
• Oncoplastic breast surgery: comprehensive review.

  2017cited by this paper
• Determining the Oncologic Safety of Autologous Fat Grafting as a Reconstructive Modality: An Institutional Review of Breast Cancer Recurrence Rates and Surgical Outcomes

  2017cited by this paper
• Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Systematic Review

  2017cited by this paper
• DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes

  2017cited by this paper
• Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer

  2017cited by this paper
• Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery.

  2017cited by this paper
• Taxanes in combination with platinum derivatives for the treatment of ovarian cancer during pregnancy: A literature review
.

  2017cited by this paper
• Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era

  2017cited by this paper
• Whole body MRI for systemic staging of breast cancer in pregnant women.

  2017cited by this paper
• Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

  2017cited by this paper
• Impact in delay of starting chemotherapy and surgery on pCR/survival in breast cancer (BC)-pooled analysis of individual patient data from six prospectively randomized neoadjuvant trials

  2017cited by this paper
• Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

  2017cited by this paper
• Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

  2017cited by this paper
• A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

  2017cited by this paper
• Determining the outcomes of post-mastectomy radiation therapy delivered to the definitive implant in patients undergoing one- and two-stage implant-based breast reconstruction: A systematic review and meta-analysis.

  2017cited by this paper
• Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.

  2017cited by this paper
• Systematic review of 3D mammography for breast cancer screening.

  2016cited by this paper
• Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force

  2016cited by this paper
• High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management.

  2016cited by this paper
• Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

  2016cited by this paper
• Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.

  2016cited by this paper
• 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

  2016cited by this paper
• MRI to Predict Nipple Involvement in Breast Cancer Patients.

  2016cited by this paper
• Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

  2016cited by this paper
• West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

  2016cited by this paper
• Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer

  2016cited by this paper
• PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

  2016cited by this paper
• Music interventions for improving psychological and physical outcomes in cancer patients.

  2016cited by this paper
• Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)

  2016cited by this paper
• Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.

  2016cited by this paper
• Management and Outcomes in Metaplastic Breast Cancer.

  2016cited by this paper
• Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation

  2016cited by this paper
• American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

  2016cited by this paper
• Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation

  2016cited by this paper

• Estudio ecográfico de la axila normal: características anatómicas de los ganglios linfáticos y variaciones de las mismas con la edad

  2025cites this paper
• Ultrasound imaging of the normal axilla: Anatomical characteristics of lymph nodes and age-related variations.

  2025cites this paper
• Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk

  2025cites this paper
• The impact of fractionation on secondary malignancies in postoperative breast cancer irradiation

  2024cites this paper
• Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis

  2024cites this paper
• Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept

  2023cites this paper
• Experiences of breast cancer survivors with exercise rehabilitation: qualitative systematic review and meta-synthesis

  2023cites this paper
• Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study

  2023cites this paper
• Providing Suggested Rules for Multiple Primary Cancer Recording, Coding and Registering in Population-based Cancer Registry

  2023cites this paper
• Preoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

  2023cites this paper
• Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.

  2023cites this paper
• Update Mammakarzinom 2021 Teil 2 – fortgeschrittene Stadien, Langzeitfolgen und Biomarker

  2022cites this paper
• Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany Initial Data from the AXSANA study Axillastaging nach neoadjuvanter Chemotherapie bei initial nodal positivem Mammakarzinom in Deutschland Erste Daten aus der AXSANA-Studie

  2022cites this paper
• Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany Initial Data from the AXSANA study Axillastaging nach neoadjuvanter Chemotherapie bei initial nodal positivem Mammakarzinom in Deutschland Erste Daten aus der AXSANA-Studie

  2022cites this paper
• Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer

  2022cites this paper
• HER2 positive breast cancer and its treatment with trastuzumab, where are we now?

  2022cites this paper
• Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien

  2022cites this paper
• Update on lobular lesions of the breast

  2022cites this paper
• Ballet after breast cancer: investigating the feasibility and acceptability of a novel 16-week classical ballet intervention for breast cancer survivors

  2022cites this paper
• Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

  2022cites this paper
• The analysis of breast cancer survival in East Azerbaijan province of Iran; prognostic impact of chemotherapy and hormone therapy protocols.

  2022cites this paper
• Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.

  2022cites this paper
• Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

  2021cites this paper
• Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes

  2021cites this paper
• Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward

  2021cites this paper
• Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients

  2021cites this paper
• Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial.

  2021cites this paper
• Gene Expression–Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial

  2021cites this paper
• Neoadjuvant and adjuvant end-points in health technology assessment in oncology.

  2021cites this paper
• Prognostic Cancer Gene Expression Signatures: Current Status and Challenges

  2021influential citation
• Prediction of neoadjuvant chemotherapy response in breast cancer

  2021cites this paper
• Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017

  2021cites this paper
• Update Mammakarzinom 2020 Teil 3 – frühes Mammakarzinom

  2021cites this paper
• Real‐World Clinical Outcomes in Biological Subgroups of Breast Cancer in the Hospital District of Southwest Finland

  2021cites this paper
• Neoadjuvant therapy for breast cancer patients and its impact on surgical treatment and radiotherapy (part 2.)

  2021cites this paper
• Update Breast Cancer 2021 Part 2 – Advanced Stages, Long-Term Consequences and Biomarkers

  2021cites this paper
• Update Breast Cancer 2021 Part 1 – Prevention and Early Stages

  2021cites this paper
• High-risk lesions of the breast: concurrent diagnostic tools and management recommendations

  2021cites this paper
• The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration

  2021cites this paper
• Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer

  2021cites this paper
• Tumor margins that lead to reoperation in breast cancer: A retrospective register study of 4,489 patients

  2021cites this paper
• Residuale axilläre Metastasenlast nach neoadjuvanter Chemotherapie (NACT) bei Patientinnen mit Mammakarzinom im Frühstadium und a priori klinisch okkulten Lymphknotenmetastasen – eine transSENTINA-Analyse

  2021influential citation
• Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?

  2021cites this paper
• Update Mammakarzinom 2021 Teil 1 – Prävention und frühe Krankheitsstadien

  2021cites this paper
• The Role of US in Depicting Axillary Metastasis in High-Risk Breast Cancer Patients

  2021cites this paper
• Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany

  2021cites this paper
• Axillastaging nach neoadjuvanter Chemotherapie bei initial nodal positivem Mammakarzinom in Deutschland – Erste Daten aus der AXSANA-Studie

  2021cites this paper
• Axillastaging nach neoadjuvanter Chemotherapie bei initial nodal positivem Mammakarzinom in Deutschland

  2021cites this paper
• Time trends of neoadjuvant chemotherapy for early breast cancer

  2020influential citation
• Moderne Therapie beim frühen Mammakarzinom

  2020influential citation
• 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina

  2020cites this paper
• Angiosarkom der Brust nach Radiotherapie

  2020cites this paper
• Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy

  2020cites this paper
• Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

  2020cites this paper
• Physician’s knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan

  2020cites this paper
• Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score

  2020cites this paper
• Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)

  2020cites this paper
• Establishment of a RESEARCH USE ONLY Condensed-Efficient-Fast (CEF) PITX2 workflow for analysis of PITX2 DNA methylation in small tumor tissue samples 

  2020cites this paper
• Adjuvant Radiotherapy for Breast Cancer: More than Meets the Eye

  2020cites this paper
• Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics

  2020cites this paper
• Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies

  2020cites this paper
• International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts

  2020cites this paper
• Publikationen-Forschung Familiärer Brust-Eierstockkrebs Uniklinik Köln

  2020cites this paper
• A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 immunohistochemistry assays for scoring in triple‐negative breast cancer

  2020cites this paper
• Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer

  2020cites this paper
• Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial

  2020cites this paper
• Werden Männer und Frauen mit Brustkrebs in Deutschland gleichbehandelt?

  2020cites this paper
• Update Mammakarzinom 2020 Teil 2 – fortgeschrittenes Mammakarzinom: neue Substanzen und Einzug diagnostikabhängiger Therapien

  2020cites this paper
• Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review

  2020cites this paper
• Update Mammakarzinom 2020 Teil 1 – frühes Mammakarzinom: Konsolidierung des Wissens über bekannte Therapien

  2020cites this paper
• A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

  2020cites this paper
• Update Breast Cancer 2020 Part 3 – Early Breast Cancer

  2020cites this paper
• Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis

  2020cites this paper
• Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial

  2020cites this paper
• Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients.

  2020cites this paper
• Role of miRNAs in regulating responses to radiotherapy in human breast cancer

  2020cites this paper
• Role of vacuum assisted excision in minimising overtreatment of ductal atypias.

  2020cites this paper
• [Are men and women with breast cancer treated equally in Germany?]

  2020cites this paper
• Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review

  2020cites this paper
• Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus

  2019influential citation
• Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019.

  2019cites this paper
• The Inaccuracy of Sentinel Lymph Node Biopsy of Breast Cancer in the Era of Precision Medicine

  2019cites this paper
• Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis – results from a registry-based study from Germany

  2019cites this paper
• Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy – German Experts’ Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019)

  2019cites this paper
• PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

  2018cites this paper